Teva Wins Risperidone Case Against FDA

Firm gets 180 days of exclusivity, though an appeal is likely, attorney tells “The Pink Sheet” DAILY.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet